SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-360850
Filing Date
2018-12-28
Accepted
2018-12-28 15:38:05
Documents
57
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d668537d10q.htm 10-Q 446636
2 EX-3 d668537dex3.htm EX-3 7226
3 EX-31.1 d668537dex311.htm EX-31.1 10462
4 EX-31.2 d668537dex312.htm EX-31.2 10542
5 EX-32 d668537dex32.htm EX-32 5182
12 GRAPHIC g668537dsp001.jpg GRAPHIC 265502
13 GRAPHIC g668537dsp002.jpg GRAPHIC 179745
14 GRAPHIC g668537dsp003.jpg GRAPHIC 199543
  Complete submission text file 0001193125-18-360850.txt   4844151

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neog-20181130.xml EX-101.INS 968796
7 XBRL TAXONOMY EXTENSION SCHEMA neog-20181130.xsd EX-101.SCH 33321
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20181130_cal.xml EX-101.CAL 46520
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20181130_def.xml EX-101.DEF 235880
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20181130_lab.xml EX-101.LAB 311416
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20181130_pre.xml EX-101.PRE 276198
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 181257324
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences